+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

From
Small Cell Lung Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Small Cell Lung Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 100 Pages
  • Global
From
From
From
Acute Myeloid Leukemia - Pipeline Insight, 2024 - Product Thumbnail Image

Acute Myeloid Leukemia - Pipeline Insight, 2024

  • Clinical Trials
  • June 2024
  • 240 Pages
  • Global
From
Self-administered Injectable Drug Therapies and Markets - Product Thumbnail Image

Self-administered Injectable Drug Therapies and Markets

  • Report
  • September 2023
  • 234 Pages
  • Global
From
From
Multiple Myeloma - Pipeline Insight, 2024 - Product Thumbnail Image

Multiple Myeloma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 230 Pages
  • Global
From
Pediatric Neuroblastoma Treatment Market Report 2025 - Product Thumbnail Image

Pediatric Neuroblastoma Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Myasthenia Gravis Treatment Market: Forecast and Trends - Product Thumbnail Image

Myasthenia Gravis Treatment Market: Forecast and Trends

  • Report
  • November 2023
  • 120 Pages
  • Global
From
From
From
Loading Indicator